Payment overview · 2025
General Payments
$134.05
7 reported records · 4 companies
Healthcare provider profile · identity verified
Chance Wayne Dingler, MD
Allopathic & Osteopathic Physicians|Family Medicine · NOCONA, TX · NPI 1780743898
Verified facts
What the public records show
CMS Open Payments records show Chance Wayne Dingler, MD received $134.05 in general payments during 2025 across 7 reported records.
Corcept Therapeutics accounted for 51.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $68.68 | 51.2% | 3 | 2025 |
| Antares Pharma, Inc. | Unresolved — no canonical attribution shown | $27.86 | 20.8% | 2 | 2025 |
| SANOFI-AVENTIS U.S. LLC | Unresolved — no canonical attribution shown | $23.69 | 17.7% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $13.82 | 10.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $134.05 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $68.68 | 3 | 2025 |
Source payment records
|
|||||
| XYOSTED Normalized: xyosted |
Drug | Antares Pharma, Inc. | $27.86 | 2 | 2025 |
Source payment records
|
|||||
| TZIELD Normalized: tzield |
Biological | SANOFI-AVENTIS U.S. LLC | $23.69 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $13.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 519 | 76 |
| Atorvastatin Calcium | Atorvastatin Calcium | 374 | 95 |
| Levothyroxine Sodium | Levothyroxine Sodium | 304 | 64 |
| Amlodipine Besylate | Amlodipine Besylate | 260 | 67 |
| Furosemide | Furosemide | 240 | 54 |
| Lisinopril | Lisinopril | 228 | 59 |
| Alprazolam | Alprazolam | 211 | 39 |
| Gabapentin | Gabapentin | 206 | 54 |
| Meloxicam | Meloxicam | 206 | 58 |
| Potassium Chloride | Potassium Chloride | 184 | 34 |
| Pantoprazole Sodium | Pantoprazole Sodium | 181 | 57 |
| Tramadol Hcl | Tramadol Hcl | 176 | 35 |
| Eliquis | Apixaban | 163 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 128 | 33 |
| Tamsulosin Hcl | Tamsulosin Hcl | 120 | 37 |
| Buspirone Hcl | Buspirone Hcl | 119 | 21 |
| Losartan Potassium | Losartan Potassium | 118 | 36 |
| Omeprazole | Omeprazole | 118 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 115 | 39 |
| Metformin Hcl | Metformin Hcl | 110 | 31 |
| Trazodone Hcl | Trazodone Hcl | 110 | 23 |
| Metoprolol Succinate | Metoprolol Succinate | 104 | 29 |
| Carvedilol | Carvedilol | 98 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 97 | 25 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 96 | 19 |
| Pregabalin | Pregabalin | 95 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 94 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 91 | 26 |
| Zolpidem Tartrate | Zolpidem Tartrate | 89 | 17 |
| Donepezil Hcl | Donepezil Hcl | 82 | 19 |
| Clonazepam | Clonazepam | 80 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 73 | suppressed |
| Spironolactone | Spironolactone | 72 | 18 |
| Temazepam | Temazepam | 72 | 12 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 71 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 70 | 18 |
| Sertraline Hcl | Sertraline Hcl | 70 | 14 |
| Warfarin Sodium | Warfarin Sodium | 68 | suppressed |
| Simvastatin | Simvastatin | 67 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 65 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 64 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 64 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 63 | 17 |
| Prednisone | Prednisone | 62 | 43 |
| Ropinirole Hcl | Ropinirole Hcl | 58 | 12 |
| Ozempic | Semaglutide | 55 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 54 | suppressed |
| Lorazepam | Lorazepam | 52 | suppressed |
| Allopurinol | Allopurinol | 49 | 13 |
| Celecoxib | Celecoxib | 49 | 14 |
| Glimepiride | Glimepiride | 49 | 15 |
| Jardiance | Empagliflozin | 49 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 47 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 47 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 46 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 44 | suppressed |
| Mirtazapine | Mirtazapine | 43 | 11 |
| Atenolol | Atenolol | 41 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | suppressed |
| Estradiol | Estradiol | 40 | 11 |
| Myrbetriq | Mirabegron | 40 | suppressed |
| Memantine Hcl | Memantine Hcl | 39 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 37 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 35 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 34 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 34 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 34 | suppressed |
| Diazepam | Diazepam | 33 | suppressed |
| Levetiracetam | Levetiracetam | 33 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 32 | suppressed |
| Digoxin | Digoxin | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Cephalexin | Cephalexin | 31 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 31 | suppressed |
| Colchicine | Colchicine | 31 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 31 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 24 |
| Dicyclomine Hcl | Dicyclomine Hcl | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | suppressed |
| Levofloxacin | Levofloxacin | 28 | 21 |
| Oxcarbazepine | Oxcarbazepine | 28 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Nifedipine Er | Nifedipine | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Xarelto | Rivaroxaban | 25 | suppressed |
| Azithromycin | Azithromycin | 24 | 19 |
| Baclofen | Baclofen | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Famotidine | Famotidine | 23 | suppressed |
| Finasteride | Finasteride | 23 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 22 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Methadone Hcl | Methadone Hcl | 22 | suppressed |
| Nystatin | Nystatin | 22 | 12 |
| Ondansetron Odt | Ondansetron | 22 | 15 |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 21 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 20 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 20 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 12 |
| Testosterone Cypionate | Testosterone Cypionate | 20 | 11 |
| Cefdinir | Cefdinir | 19 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Calcitriol | Calcitriol | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 12 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 16 | 12 |
| Glipizide Er | Glipizide | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Armour Thyroid | Thyroid,pork | 12 | suppressed |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $134.05 · 7 records | Corcept Therapeutics | Cologuard Collection Kit, Korlym, TZIELD, XYOSTED | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error